The Black Technology Era of Xueba

Xiao Ming returned to Prajna Village.

Before the industrial park was built, Banruo Village was the largest base of Pangu Technology.

So far, except for the Yigou Business Department and the System Business Department, which are located in Guangyao Building, the rest of the departments are located in Prajna Village.

Gao Siqi reported the specific situation to Xiao Ming, which sounded more serious than expected.

Even if Pangu Technology successfully treats a patient, and even if Pangu Technology publishes a paper, from the perspective of clinical therapeutic effect, the appearance of inhibitory gene therapy technology and nivolumab treatment is similar.

Especially waiting for cancer cells to die, which is the most typical manifestation of PD-1 inhibition.

Gao Siqi said: "On the surface, the status and indicators of the patients who were successfully treated were similar, so Bristol-Myers Squibb determined that we were embezzling his intellectual property."

Xiao Ming said helplessly: "From the last indicator, if nivolumab really has a significant effect on patients, then there is no difference between the two, because everyone's indicators are close to normal, but in essence, the two is absolutely different."

"What if we don't accept lawyer's letters?"

"It will be sued." Gao Siqi said: "Xia Guo has joined 26 international intellectual property convention organizations including the "Convention on the Establishment of the World Intellectual Property Organization", and high-tech intellectual property rights such as the medical field are subject to national restrictions Strict protection."

In addition to intellectual property rights, what Guibao cares about in its implementation is the market profit of 100 billion meters of knives.

The cost of nivolumab treatment is 40,000 yuan per month and 480,000 yuan per year.

Based on a patient's five-year life expectancy, the patient would spend $2.4 million.

And what about the treatment technology of Pangu Technology? About 300,000 can be restored to a healthy person.

Moreover, the therapeutic effect of targeted drugs depends on the probability, and there is no 100% certainty.

The patient is not a fool and will definitely seek treatment from Pangu Technology.

In the foreseeable future, when suppressive gene therapy conquers more cancers, this market will be left without the living space for pharmaceutical companies such as Bristol-Myers Squibb and Bayer that develop targeted therapy drugs.

All patients and treatment costs will flow to Xia Guo, to the medical institutions centered on Pangu Technology.

The transfer of global medical centers to the Xia Kingdom is the most terrifying and most worrying for Western society.

"If the other party sues us, no matter what the ultimate truth is, the qualification for clinical treatment using our gene expression suppression technology will be suspended internationally."

"Internationally?" Xiao Ming asked.

"Yes, internationally. This will influence us to vigorously promote this technology into the clinic."

Among the 26 related intellectual property rights and patents, the agreement for high-end cutting-edge sciences such as life sciences is that if there is a dispute between the two parties, the related patented products of both parties will be stopped at the same time in the member states of intellectual property rights, waiting for the two parties to reach an agreement or finally Only after the arbitration can Yifang continue to use the patented product.

"What about in China?" Xiao Ming is more concerned about domestic problems. After all, the international promotion of technology is still relatively far away.

Gao Siqi's words made Xiao Ming feel that her brain was a little short-circuited. She said: "For other countries, Xia Guo is also a member of the international organization, so the ban is effective for Xia Guo."

Xiao Ming: "...Really cruel."

Gao Siqi has studied this comparison and said: "The rules are set by people. Usually, the other party has no definite evidence to prove our infringement. We can still use this technology clinically in our country, but we just have to fight."

Xiao Ming said: "It is indeed a good thing for Pangu Technology, and we have to take this opportunity to prove to the world that Xia Guo's medical field has already taken the lead in the world."

Gao Siqi said: "Actually, as long as it depends on the attitude of Jiangcheng University and relevant departments."

Gao Siqi analyzed: "Xia Guo is now in line with international standards in the field of intellectual property, and hopes to establish an image of intellectual property protection in the world. Xia Guo hopes to throw away the hat of theft and copycat in the world,

In this way, Xia Guo can introduce more and more advanced technology. "

Internationally, countries led by the United States and the European Union have accused Xia of stealing other countries' intellectual property.

The United States has also set a technology embargo on China. The reason for the embargo is that Xia does not respect intellectual property rights in science and technology, and the technology embargo is also the reason why the United States has a huge trade deficit with Xia.

Xia Guo now wants to show everyone that he also respects intellectual property rights. In fact, he does not know that discrimination against Xia Guo is inherent in the international community. No matter how hard you try, you will not be able to change the views of the United States and Europe towards you.

Xiao Ming said: "When we develop technology, we don't need to care about the feelings of the international community. What we need to care about is the feelings of patients."

"So?" Gao Siqi said, "Ignore it?"

"Of course don't pay attention. We don't fight with each other. Whether Bristol-Myers Squibb Company or the United States, if there is any objection to our technology, then use evidence to speak."

Xiao Ming sneered and said, "We are not opposed to treating patients in the United States. If the Americans set up obstacles for us, only ordinary people in the United States will be injured."

Gao Siqi said: "Yes! We develop our technology, and it is the people of Xia who are being treated. What's the matter with these Americans!"

In front of Xiao Ming, Gao Siqi tore up the other party's lawyer's letter.

Sure enough, two days later, Bristol-Myers Squibb took further steps.

First, they published an article in the New York Times, pointing out that Pangu Technology plagiarized technology, and gave a lot of examples.

For example, Bristol-Myers Squibb Company successfully used nivolumab to treat liver cancer patients five years ago. For example, the color Doppler ultrasound and blood indicators of patients using nivolumab are similar to those published by Pangu Technology using gene expression inhibition therapy.

At the same time, Bristol-Myers Squibb Company sued Pangu Technology in the local court in New York, demanding that Pangu Technology immediately prohibit the use of gene expression suppression therapy to treat patients, apologize to Bristol-Myers Squibb Company, and compensate Bristol-Myers Squibb Company 1 billion meters in accordance with relevant regulations on intellectual property infringement! Also asked the US FDA (Food and Drug Administration) to impose a fine on Pangu Technology!

This is quite excessive, and it is equivalent to Bristol-Myers Squibb asking the United States to use the local laws of the United States to adjudicate a Xiaguo company!

This seemingly arrogant request is actually a consistent method of the Americans, replacing international laws with domestic laws of the United States, and even the laws of the Xia Kingdom.

At the beginning, Xiaguo companies such as Warwick and Center have all suffered such treatment.

The matter is really as expected by Bristol-Myers Squibb. The US FDA raised serious concerns to the relevant departments of Xia Guo and asked the Affiliated Hospital of Jiangcheng University to stop using gene expression suppression therapy to treat patients.

At the same time, the New York court formally accepted the case.

Genius for a second to remember the address of this site: . Mobile version reading website: